Manon Queudeville
Overview
Explore the profile of Manon Queudeville including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heinz A, Grumaz S, Slavetinsky C, Doring M, Queudeville M, Handgretinger R, et al.
Front Cell Infect Microbiol
. 2024 Jul;
14:1355787.
PMID: 38975323
The etiology of pediatric acute lymphatic leukemia (ALL) is still unclear. Whole-metagenome shotgun sequencing of bone marrow samples in patients with treatment-naïve ALL (n=6) was performed for untargeted investigation of...
2.
Schober S, Rottenberger J, Hilz J, Schmid E, Ebinger M, Feuchtinger T, et al.
Cancer Immunol Immunother
. 2023 Aug;
72(11):3621-3634.
PMID: 37610672
Immune milieus play an important role in various types of cancer. The present study focuses on the effect of Th1 cytokines on pediatric acute lymphoblastic leukemia (ALL). The reaction of...
3.
Flaadt T, Ladenstein R, Ebinger M, Lode H, Arnardottir H, Poetschger U, et al.
J Clin Oncol
. 2023 Feb;
41(17):3135-3148.
PMID: 36854071
Purpose: Patients with relapsed high-risk neuroblastoma (rHR-NB) have a poor prognosis. We hypothesized that graft-versus-neuroblastoma effects could be elicited by transplantation of haploidentical stem cells (haplo-SCT) exploiting cytotoxic functions of...
4.
Queudeville M, Stein A, Locatelli F, Ebinger M, Handgretinger R, Gokbuget N, et al.
Cancer
. 2023 Feb;
129(9):1384-1393.
PMID: 36829303
Background: A lower baseline bone marrow blast percentage (bBMB%) is associated with better outcomes in patients with B-cell acute lymphoblastic leukemia (B-ALL) receiving blinatumomab. The objective of this analysis was...
5.
Gorodezki D, Zipfel J, Queudeville M, Holzer U, Bevot A, Schittenhelm J, et al.
Int J Cancer
. 2022 Dec;
152(9):1875-1883.
PMID: 36522830
In addition to surgical management, corticosteroids have proven to be beneficial in the management of acute symptoms related to CNS tumors, and have been widely used for many decades, with...
6.
Gorodezki D, Zipfel J, Queudeville M, Sosa J, Holzer U, Kern J, et al.
J Neurooncol
. 2022 Nov;
160(3):567-576.
PMID: 36319795
Purpose: Despite excellent long-term overall survival rates, pediatric low-grade gliomas (pLGG) show high variety of clinical behavior regarding progress or senescence post incomplete resection (IR). This study retrospectively analyzes tumor...
7.
Stagno M, Schmidt A, Bochem J, Urla C, Handgretinger R, Cabanillas Stanchi K, et al.
Br J Cancer
. 2022 Jul;
127(7):1324-1331.
PMID: 35864157
Background: Neuroblastoma (NB) is the most common paediatric extracranial solid malignancy. We analysed the role of the epitope detection in monocytes (EDIM) technique for liquid biopsy in NB patients. Methods:...
8.
Heinz A, Eichholz T, Queudeville M, Hartmann U, Ott A, Heinzel O, et al.
Pediatr Hematol Oncol
. 2021 Nov;
39(4):357-364.
PMID: 34752206
Hypotonic fluids are commonly used in pediatric oncology despite evidence that these fluids can lead to hospital-acquired hyponatremia. This practice is most likely due to lack of data evaluating risks...
9.
Queudeville M, Ebinger M
J Clin Med
. 2021 Jul;
10(12).
PMID: 34201368
Acute lymphoblastic leukemia is by far the most common malignancy in children, and new immunotherapeutic approaches will clearly change the way we treat our patients in future years. Blinatumomab is...
10.
Riegg F, Lutz M, Schmied B, Heitmann J, Queudeville M, Lang P, et al.
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33915811
In recent decades, antibody-dependent cellular cytotoxicity (ADCC)-inducing monoclonal antibodies (mAbs) have revolutionized cancer immunotherapy, and Fc engineering strategies have been utilized to further improve efficacy. A promising option is to...